The "Ambulatory IV Infusion Pumps Market"is anticipated to increase from USD xxx billion in 2023 to USD xxx billion by 2031, with a strong compound annual growth rate (CAGR) of xxx% from 2024 to 2031.

An ambulatory infusion pump, such as a Deltec CADD, is used to deliver the drug (occasionally, hospitalized patients may be switched to a general purpose pump). A major risk is interruption of ...

The intravenous infusion pumps market is set to grow from US$ 6.2 Bn in 2024 to US$ 11.4 Bn by 2031, registering a CAGR of 8.5% during 2024-2031. LOS ANGELES, CA, UNITED STATES, February 13 ...

Ambulatory Infusion Center Market is expected to reach USD 95.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031. BURLINGAME, CA ...

Moreover, rise in demand for ambulatory infusion pumps in home care settings, also fuel the growth of the market. However, stringent governmental regulations and reforms associated with infusion ...

Epoprostenol sodium is delivered by continuous i.v. administration using an ambulatory infusion pump through an indwelling, surgically implanted central line. Treprostinil sodium, which has a ...

In this conference, it was emphasised that a high percentage of sentinel/drug-adverse events are due to pump use errors and that it is necessary to improve the safety features of the design and define ...

Immersiv Health says with its model, everyone, including the patient, physician and insurance company, can “win.” In May 2024, CEO Son Hee Han launched Immersiv Health, an ambulatory infusion company.

US medical device maker Becton, Dickinson & Co. (BD) has decided to close its manufacturing plant in Israel and lay off 200 employees as part of an effort to streamline its global operations and ...